- Incredibly small footprint making it perfect for point-of-care and small volume clinics.
- With fast and definitive test results in mere minutes, patients can be tested and begin treatment in the same office visit. If desired, results can be printed out immediately as soon as they are available.
- 100% Sensitivity and Specificity in clinical trials. Outstanding diagnostic performance even with patient taking Proton Pump Inhibitor (PPI) medication (98.4% Sensitivity and 99.2% specificity).
- One-button, intuitive touchscreen interface simplifying operations. No attached computer required.
- Innovative horizonal collection bag hook-up prevents patient saliva from dripping down into the analyzer, saving maintenance and maximizing product performance.
- Unlike many other
H. pylori non-invasive diagnostic tests, patients may not have to stop taking their proton pump inhibitor (PPI) medications.
- Robust product reliability with low maintenance requirements, backed by unparalleled customer support. Integrated self-test at the simple touch of a button.
- The test for initial detection AND the test to confirm infection eradication are BOTH reimbursable with established CPT codes (UBT Test Administration: 83013, UBT Test Analysis: 83014)
- CLIA non-regulated; no special certification needed.
- LIS-compatible: secure direct connection to LIS-systems.
- W 7.6" (195mm) X D 17.7" (450mm) X H 9.4" (240mm)
19.8lbs (9kg)
Note: This is our latest generation 2-port analyzer, which is still pending approval in some countries. The previous generation has all the same features and functionality with the exception of networking capabilities.